Jubiglim MV 1mg/500mg/0.3mg Tablet
Marketer
Jubilant Life Sciences
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.3mg)
Overview Jubiglim MV 1mg/500mg/0.3mg Tablet
DiabetaComb 1mg/500mg/0.3mg tablets are classified as antidiabetic medications. This combination drug treats type 2 diabetes in adults by helping regulate blood glucose. DiabetaComb should be taken with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on blood sugar response. Continue this medication even with controlled blood sugar or feeling well; discontinuation without physician consultation risks elevated blood glucose, potentially leading to kidney problems, vision loss, neuropathy, and limb complications. Remember, it's part of a comprehensive treatment plan including diet, exercise, and weight management as advised by your doctor—lifestyle significantly impacts diabetes control. Hypoglycemia (low blood sugar) is a common side effect. Learn to recognize its symptoms (sweating, dizziness, headache, tremors) and manage them accordingly. Consistent meals and readily available glucose (sugary foods, juice) are crucial. Alcohol increases hypoglycemia risk and should be avoided. Additional possible side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, fractures, and upper respiratory infections; weight gain may also occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver disease. Inform your doctor of any heart condition history before commencing treatment; pregnancy or breastfeeding requires medical consultation. Regular blood sugar monitoring is essential, and your doctor may order blood tests to check blood cell counts and liver function.
Uses of Jubiglim MV 1mg/500mg/0.3mg Tablet
Managing type 2 diabetes
Major Benefits of Jubiglim MV 1mg/500mg/0.3mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Jubiglim MV 1mg/500mg/0.3mg Tablet on an empty stomach.
Common Side effects of Jubiglim MV 1mg/500mg/0.3mg Tablet:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Jubiglim MV 1mg/500mg/0.3mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Jubiglim MV 1mg/500mg/0.3mg Tablet on an empty stomach.
How Jubiglim MV 1mg/500mg/0.3mg Tablet works:
One tablet of Jubiglim MV contains 1mg, 500mg, and 0.3mg of three distinct antidiabetic agents.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Jubiglim MV 1mg/500mg/0.3mg Tablet is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Use of Jubiglim MV 1mg/500mg/0.3mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against possible risks prior to prescribing. Seek medical advice before taking this medication.
Breast feedingCONSULT YOUR DOCTOR
The use of Jubiglim MV 1mg/500mg/0.3mg tablets while breastfeeding is likely inadvisable. Available human data indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyUNSAFE
Patients with kidney disease should likely avoid Jubiglim MV 1mg/500mg/0.3mg Tablets due to potential safety concerns. Medical advice is recommended. The use of Jubiglim MV 1mg/500mg/0.3mg Tablets is contraindicated in those with severe kidney impairment.
LiverCAUTION
Exercise caution when administering Jubiglim MV 1mg/500mg/0.3mg tablets to individuals with hepatic impairment. Dosage modification may be necessary. Physician consultation is advised. For patients experiencing mild to moderate liver dysfunction, initiate Jubiglim MV 1mg/500mg/0.3mg treatment with a reduced dosage; its use is contraindicated in those with severe liver disease.
What if you forget to take Jubiglim MV 1mg/500mg/0.3mg Tablet :
Should you forget a Jubiglim MV 1mg/500mg/0.3mg Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Jubiglim MV 1mg/500mg/0.3mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently